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We have constructed human immunodeficiency virus (HIV) gag mutants by increasing the matrix protein (MA) sequences
via tandemly repeated duplication of the central 107-MA codons. Instead of a total of 132 amino acid residues for the
wild-type MA, the resultant mutants designated as MA2, MA3, and MA4 contained a total of 242, 352, and 462 codons in the
MA domains, respectively. Analysis indicated that the addition of 110 or 220 amino acid residues to the MA did not
significantly affect the assembly, release, and processing of particles; however, particle production was markedly reduced
when another copy of 110 residues was added to the MA. Subcellular fractionation analysis suggested that the MA tandem
repeat mutations enhanced the Gag membrane affinity, in a manner which correlated with the copy number of MA sequences.
The effects of enhanced membrane affinity were substantially reduced when sequences downstream of the capsid (CA)
domain were deleted. Sucrose density gradient fractionation analysis showed that particles produced by the large insertion
mutants possessed wild-type (wt) HIV particle density. Truncation of sequences downstream of the nucleocapsid (NC)
domains of the mutants did not influence the budding of particles. In contrast, particle budding was severely impaired when
sequences downstream of the CA domain were truncated. Particle densities for the large Gag proteins, which were truncated
at the C-terminus of CA, were about 1.12–1.14 g/ml lower than that for wt. Our results suggest that the HIV MA domain could
adopt insertions of large protein sequences, and strongly support the proposal that the NC and p2 domains play a crucial
role in the process of correct Gag protein packing. © 2000 Academic PressINTRODUCTION
The human immunodeficiency virus (HIV) core protein
Gag is synthesized initially as the precursor Pr55 (Mervis
et al., 1988; Ratner et al., 1985). During or after virus
budding, the Pr55gag is cleaved by the viral protease (PR)
into four major products: the matrix protein (p17; MA),
capsid domain (p24; CA), nucleocapsid (p7; NC), and the
C-terminal p6 domain (Henderson et al., 1992; Kaplan et
l., 1994; Leis et al., 1988; Mervis et al., 1988). A number
of specific functions involved in the HIV life cycle have
been identified and ascribed to the individual domains
(Freed, 1998). It is clear that expression of the Pr55gag
alone is sufficient for assembly and release of viruslike
particles (Gheysen et al., 1989). Protein sequences in-
volved in Gag–Gag interaction are located throughout
the Pr55gag and Gag multimerization appears to require
cooperative interactions between several domains
within the Pr55gag (Freed, 1998; Hunter, 1994). For exam-
ple, the NC has been proposed, in conjunction with the
major capsid (CA) domain, to facilitate Gag multimeriza-
tion and particle formation (Bowzard et al., 1998; Buriston
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289et al., 1999; Dawson and Yu, 1998; Franke et al., 1994;
McDermott et al., 1996; Zhang et al., 1998). A region
designated the “I” (interaction) domain has been mapped
to the NC domain (Parent et al., 1995).
Concerning the functions of the MA domain in the
process of Gag particle assembly, genetic analysis indi-
cates that the efficient plasma membrane binding of Gag
is coordinated by the N-terminal myristic acid moiety and
a stretch of N-proximal basic residues (Facke et al., 1993;
Hill et al., 1996; Ono and Freed, 1999; Ono et al., 2000;
Zhou et al., 1994). Mutations within the “M” (membrane
binding) domain may abolish particle production as a
result of severely impaired Gag membrane binding and
plasma membrane targeting (Bryant and Ratner, 1990;
Freed et al., 1994; Gottlinger et al., 1989; Ono et al., 2000;
Pal et al., 1990). While subtle mutations in the MA domain
cause significant reductions in particle release (Freed et
al., 1994; Reicin et al., 1995; Wang and Barklis, 1993; Yuan
et al., 1993), a deletion of the central 105 codons (Wang
et al., 1993) or substitution of the whole MA domain with
the Src myristylation signal appear to have no major
effects on particle assembly and release (Lee and Linial,
1994; Reil et al., 1998; Wills et al., 1991). Moreover, it has
been shown that the clusters of basic residues from HIV
MA protein could rescue the budding defects of Rous
sarcoma virus (RSV) MA deletion mutants (Parent et al.,
1996). One possible explanation for this discrepancy is
0042-6822/00 $35.00
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290 WANG, CHEN, AND CHIANGthat deleterious effects of the smaller mutations on par-
ticle assembly have been removed in the MA deletion
mutants.
We demonstrated previously that HIV Gag proteins
consisting of the myristic acid signal sequences, CA, and
the p2 domain were still assembled and released as
viruslike particles (Wang et al., 1998). A more recent
study reported that expression of the C-terminal half HIV
gag sequences was sufficient for efficient particle as-
sembly (Borsetti et al., 1998). Additionally, heterologous
gag sequences or gag-unrelated sequences can substi-
tute for or be fused to the HIV C-terminal Gag sequences,
leading to the production of chimeric viruslike particles
(Bennett et al., 1993; Weldon et al., 1990, 1993; Wills et al.,
994; Zhang et al., 1998). We found that an HIV gag
utant produced viruslike particles efficiently when the
A either contained an additional 110 amino acid resi-
ues (Wang et al., 2000a) or was partially replaced by an
nactivated HIV PR domain (Wang et al., 2000b). These
esults suggest that the HIV gag can tolerate large de-
etion mutations or can adapt to insertions of large pro-
ein sequences. However, it is unclear to what extent
xtra coding sequences can be inserted into the HIV gag
ithout significantly compromising particle assembly
nd release.
In this study, we constructed HIV MA tandem repeat
utants by duplication, triplication, or quadruplication of
he MA central coding sequences, and analyzed the
embrane binding, assembly, and release of the mu-
ants. Our analyses indicated that mutants containing
wo (MA2) or three copies (MA3) of the MA sequences
ere still assembled and released at levels of over 50%
f that of the wild-type. Despite the size increase of about
.6-fold over that of wt Gag, the large recombinant Gag
roteins were assembled into particles with a wt HIV
article density. However, the densities of the large Gag
articles became reduced compared to those of wt par-
icles when sequences downstream of the CA C-termi-
us were truncated, suggesting an altered morphology
f the mutant particles.
RESULTS
To test to what degree the HIV MA region can with-
tand insertions of extra protein sequences, the central
05 residues of the MA domain were duplicated, tripli-
ated, or quadruplicated, and the resultant gag mutants
ere analyzed for their ability to assemble and release
irus particles. As illustrated in Fig. 1A, the MA tandem
epeat mutants (designated MA2, MA3, and MA4) con-
ain a total of an additional 110, 220, and 330 amino acid
esidues, respectively, in the MA domain. Wild-type and
utant HIV gpt constructs were transiently transfected
nto 293T cells and the expression and release of Gag
gagroteins were probed with an anti-p24 monoclonal
antibody. As shown in Fig. 1B, the MA2, MA3, and MA4precursors were detected as bands of molecular weights
68, 81, and 94 kDa, respectively, corresponding to the wt
Pr55gag with the insertions of additional duplicated MA
equences (Fig. 1B, lanes 3–5). Bands migrating at po-
itions corresponding to the wt p41 with the added MA
opies were also clearly detected for each mutant. The
evels of the released MA2 and MA3 Gag proteins were
oughly comparable to that of WT (Fig. 1B, lanes 7–9),
ndicating that the addition of 110 or 220 residues to the
A region did not significantly affect HIV Gag release. In
ontrast, the release of MA4 was remarkably reduced
Fig. 1B, lane 10), suggesting that Gag release was se-
erely impaired when the number of residues in the MA
ad been increased to a total of 462.
To confirm that the MA mutants did indeed express the
arge recombinant matrix proteins, the membrane from
ig. 1B was probed with a monoclonal antibody specifi-
ally directed against the mature p17MA and p17-asso-
iated Gag proteins consistent with the predicted molec-
lar mass of the WT, MA2, MA3, and MA4 (p17, p30, p43,
nd p56, respectively) were readily observed (data not
hown). These results indicate that the mutants did con-
ain the extra protein sequence insertions in the MA
omains and that the large insertion mutations had no
ignificant effects on HIV Gag processing. A band mi-
rating with the wt p41gag was seen in cell samples of all
A mutants (Fig. 1B, lanes 3–5). This Gag product pos-
ibly represented the incompletely cleaved p24-p2-p7-
1-p6 (Mervis et al., 1988).
Reduction of the Gag sizes by deletion of sequences
dispensable for virus budding did not significantly
improve the Gag release efficiency
The results given above suggested that HIV gag mu-
tants containing an additional 110 or 220 residues in the
MA regions were still competent in Gag particle assem-
bly and release. Because it was reported that HIV Gag
particles could still be produced without the p7NC and
p6 domains, we next examined the effects of C-terminal
truncations on the assembly and release of the MA
tandem repeat mutants. To do so, HIV gag sequences
downstream of codon 449, 431, or 336 were truncated
and the resultant mutations were introduced into the WT
and MA mutants. As illustrated in Fig. 2A, constructs
designated T449, MA2T449, MA3T449, and MA4T449
lacked the p6 domain; T431, MA2T431, MA3T431, and
MA4T431 had the p6 and p1 domains deleted; and T336,
MA2T336, MA3T336, and MA4T336 were truncated at
the C-terminus of the CA domain. The PR domains in the
C-terminal truncation mutants were either inactivated or
truncated. The results show that all mutants except the
MA4 double mutants (Fig. 2B, lane 11; Fig. 2C, lane 13;
Fig. 2D, lane 11) were assembled and released, as the
mutant precursors were clearly observed in the medium
supernatant samples. In some cases, bands migrating
a thod as
m nd p24
291ASSEMBLY OF HIV-1 MATRIX MUTANTSeither faster or slower than those of the predicted mutant
precursors were seen in the cell samples. These bands
might have been the result of intracellular Gag protein
degradation, aberrant processing, or incomplete dena-
turation of the samples.
To evaluate the effects of gag mutations on HIV
assembly and release, Gag protein levels were quan-
titated with a scanning densitometer and ratios of total
Gag proteins in the medium supernatants versus cells
were determined. For comparison with WT, ratios ob-
tained with each mutant were divided by the WT ratios
in parallel experiments. The results shown in Fig. 2E
FIG. 1. (A) Schematic representations of wild-type (WT) and recombin
The WT encodes a matrix protein of 132 codons. The MA2 contains a d
contain two and three additional copies of the duplicated 107 codons in
by three foreign residues (boldfaced). The encoded matrix domains o
residues, respectively. All constructs were expressed in the HIVgpt bac
posttransfection, supernatants and cells were collected and prepared
samples (lanes 6 to 10), corresponding to 50% of the total samples, an
fractionated by SDS–10% PAGE and electroblotted onto nitrocellulose
ntibody. Specific interactions were visualized using a colorimetric me
arkers are indicated on the right. Wild-type Gag proteins Pr55, p41, aindicate that the MA2 and MA3 were released effi-
ciently because their ratios were comparable to that ofthe WT, while of the MA4 release efficiency was less
than 10% of WT levels. Removal of the p6 (MA4T449) or
p6 plus p1 (MA4T431) did not appear to improve the
MA4 release. Similarly, all the MA4 double mutants
and mutants lacking the NC and p2 domains (T366
versions) were also released at remarkably reduced
levels compared to that of the WT in parallel experi-
ments (Fig. 2E). These results suggest that the bud-
ding defect of MA4 is not solely the result of size
constraint and that the C-terminal p7NC and p2 do-
mains are required for efficient virus budding. The
release efficiency levels of mutants T449, MA2T449,
gag constructs. Mature processed Gag protein domains are indicated.
tion of 107 codons (residues 15 to 121, underlined). The MA3 and MA4
A domain, respectively, with the tandem repeat 107-MA codons linked
A2, MA3, and MA4 contain a total of 242, 352, and 462 amino acid
. (B) 293T cells were transfected with the indicated constructs. At 48 h
ein analysis as described under Materials and Methods. Supernatant
amples (lanes 1 to 5), corresponding to 5% of the total samples, were
IV Gag proteins were detected with a mouse anti-p24gag monoclonal
described under Materials and Methods. Positions of molecular size
are marked on the left.ant HIV
uplica
the M
f the M
kbone
for prot
d cell s
filters. HT431, MA2T431, and MA3T431 were even higher than
that of the WT (Fig. 2E). This could result from an
r292 WANG, CHEN, AND CHIANGFIG. 2. (A) Schematic representations of recombinant HIV gag constructs. Constructs T449, T431, and T366 contain termination codons substituted
for residues 449, 431, and 366, resulting in truncations of the p6, p6 1 p1, and p6 1 p1 1 p7NC 1 p2, respectively. Introduction of the termination
mutations into the MA2, MA3, and MA4 shown in Fig. 1A generated the designated double mutants. (B–D) Assembly and release of HIV Gag proteins.
Medium supernatant and cell samples of 293T cells transiently transfected with the designated constructs were prepared and analyzed by Western
gagimmunoblotting using an anti-p24 monoclonal antibody as described under Materials and Methods. Molecular weight markers are indicated on the
ight and HIV Gag proteins Pr55, p41, and p24 are shown on the left. (E) Relative levels of Gag protein release. Gag proteins from medium or cell
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293ASSEMBLY OF HIV-1 MATRIX MUTANTSincreased rate of assembly and/or intracellular mutant
Gag protein degradation.
One possible cause of the severe budding defects that
were observed with the MA4 double mutants (MA4T449,
MA4T431, and MA4T366) could be an impairment of Gag
transport and assembly. However, significant amounts of
these mutants were released into the culture media
when cotransfected into 293T cells with a Pr55gag expres-
sion plasmid (Fig. 3, lanes 15–17), suggesting that there
was efficient incorporation of the mutant Gag into Pr55gag
particles. The I-domain-lacking mutant MA4T366 was
rescued as well as the mutants with intact I domains.
This indicates that the double mutations have no major
effects on the interaction between mutant Gag and the
wild-type Pr55gag, and that the I domain may not be
irectly involved in the process of Gag–Gag interactions.
ucrose density gradient fractionation analysis of HIV
ag mutants
Because the finding that such large recombinant HIV
ag proteins could still be assembled and released was
nusual, we performed sucrose density gradient frac-
ionation experiments to examine particle densities of
he mutants. To compare with wild-type HIV particles in
arallel, mutant viral pellets were spun with the WT
ellets through the same sucrose density gradients. As
hown in Fig. 4, Gag proteins in particles produced by
he constructs MA2, MA3, and MA4 cosedimented with
FIG. 3. Incorporation of assembly-defective mutants into HIV Gag par
individually or cotransfected (lanes 5–8 and 14–17) with a Pr55gag expre
f the MA4 and an HIV-1 protease-defective (PR2) mutant. At 48 to 7
fractionated by SDS–8% PAGE. Gag proteins in the medium and cell sam
ntibody. Molecular size markers are shown on the right and the wild-ty
samples were quantitated by scanning mutant and wild-type Pr55, p41,
levels in the media versus cells were calculated for each construct. The
experiments. Values of the ratios thus indicate the relative levels of Gag protei
from three experiments for each construct.he WT Gag proteins and banded in fractions with den-
ities between 1.161 to 1.179 g/ml (Fig. 4A), which is
onsistent with wild-type retrovirus particle densities.
he faint band of MA4 (fraction 5) reflected the severe
mpairment in MA4 release. Similarly, the MA2T449,
A3T449, MA4T449, MA2T431, MA3T431, and MA4T431
articles also showed peaked fractions with densities of
.16 to 1.18 g/ml (data not shown). In contrast, the densi-
ies of T366, MA2T366, and MA3T366 were about 1.126 to
.141 g/ml (Fig. 4B), much lower than the wild-type HIV
ag particle density, indicating an altered morphology.
o further test whether these mutant particles were
embrane-enveloped, mutant transfectant supernatants
ere treated with trypsin prior to centrifugation as de-
cribed previously (Wang et al., 1998). The results
howed that the mutant and wild-type Gag proteins were
elletable following trypsin treatment, indicating that the
utant Gag proteins were contained within particles
data not shown). These results suggested that released
ag proteins were particle associated and that the levels
f pelletable Gag proteins in medium reflected the levels
f virus particles.
he matrix tandem repeat mutations enhanced the
inding of Gag to cellular membranes
Because some mutations within the MA domains
ould lead to redistribution or mislocalization of the Gag
recursors (Facke et al., 1993; Ono et al., 2000; Wang and
he indicated constructs were either transfected (lanes 1–4 and 10–13)
lasmid into 293T cells. The MA4/PR2 was derived from a combination
ttransfection, culture media and cells were collected, prepared, and
ere detected by immunoblotting using a mouse anti-p24gag monoclonal
Pr55gag and mutant MA4/PR2 precursor Pr94 are indicated on the left.
4/25 band densities from immunoblots. Ratios of the total Gag protein
of the Gag mutant constructs were normalized to that of WT in parallelticles. T
ssion p
2 h posand p2
ratiosn release. Error bars indicate standard deviations, which were derived
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294 WANG, CHEN, AND CHIANGBarklis, 1993), and because both the MA and NC do-
mains were previously shown to be involved in Gag
membrane binding, we next analyzed the effects of the
additional MA sequences on Gag membrane binding in
the presence or absence of the C-terminal Gag se-
quences. To exclude possible effects of Gag processing
on estimation of the amounts of membrane-associated
Gag precursors, the wild-type and mutants were ex-
pressed in a PR-defective (PR2) version. Transfected
293T cells were fractionated to isolate the crude mem-
brane (P) and cytosol (S) fractions, which were subjected
to immunoblotting analysis as described under Materials
and Methods. Figure 5A shows that most of the wild-type
Gag proteins were seen in the membrane pellets under
physiologic salt conditions (0.15 M NaCl). In contrast,
less than 30% of the T366 were membrane-associated.
These data agree with the previous studies and support
the proposal that the C-terminal Gag sequences contrib-
FIG. 4. Sucrose density gradient fractionation of HIV Gag particles.
293T cells were transfected with the WT, mutants, and a Pr55gag ex-
pression plasmid. At 48 to 72 h posttransfection, supernatants were
collected and pelleted through 20% sucrose cushions. Viral pellets
were suspended in TSE buffer. For direct comparison with wild-type
HIV particle densities, WT viral pellets (A) or Pr55gag pellets (B) were
spun through the same sucrose density gradient with the pooled
pellets of MA2, MA3, and MA4 (A), or with mutant pellets of T366,
MA2T366, and MA3T366 (B). Fractions were collected from top to
bottom, measured for density, and analyzed for Gag protein levels by
immunoblot detection using an anti-p17gag (A) or an anti-p24gag (B)
antibody. Densities of designated fractions are indicated at the top.
Positions of mutant and wt HIV Gag proteins are shown on the left.ute significantly to Gag membrane binding (Platt and
Haffar, 1994; Sandefur et al., 1998; Spearman et al., 1994).The NC domain may provide for cooperative interactions
that enable the whole Gag molecules to bind more tightly
to the membrane. Interestingly, MA tandem repeat mu-
tants, particularly the MA3 and MA4, were found mostly
in the pellet fractions; the extent of Gag membrane as-
sociation was somewhat correlated to the copy number
of inserted MA sequences. Similarly, the double mutants
MA2T366, MA3T338, and MA4T366 were seen mostly in
the pellet fractions than in T366. While most of the mu-
tant Gag proteins remained in the pellet fractions under
physiologic conditions, substantial amounts of the mu-
tants were, however, found in the soluble (cytosolic)
fractions when treated with 1 M NaCl (Fig. 5B). Because
membrane-free Gag proteins could aggregate into large
protein complexes and cosediment with the membrane
pellets, data from the subcellular fractionation experi-
ments may not accurately reflect the levels of mem-
brane-bound proteins. We performed membrane flotation
centrifugation experiments (Ono and Freed, 1999) to an-
alyze the levels of membrane-associated Gag mutants
under low-salt versus high-salt conditions. The results
indicate that the MA mutations did enhance the Gag
membrane binding under low-salt conditions (unpub-
lished data), which is consistent with the results of the
subcellular fractionation experiments.
DISCUSSION
It was previously shown that retroviral mutants with
insertions of heterologous protein sequences in the gag
region can still produce viruslike particles (Bennett et al.,
1993; Wang et al., 2000; Weldon and Wills, 1993; Wills et
l., 1994; Zhang et al., 1998). However, it is not known to
hat degree extra coding sequences could be added to
he gag without significantly affecting virus particle as-
embly and release. Here, we demonstrated that HIV
ag proteins containing an additional 110 or 220 resi-
ues inserted in the MA domain were assembled, re-
eased, and processed as well as the wild-type. More-
ver, viruslike particles could still be detected in the
edium when the size of the recombinant Gag (MA4)
ad been increased about 1.6-fold that of wild-type
r55gag. These results indicate that the MA tandem re-
peat mutations did not significantly affect particle assem-
bly and processing in 293T cells and that the HIV gag
can tolerate large insertions of extra protein sequences
without losing its ability to direct viruslike particle assem-
bly and release.
Whereas most assembly-competent chimeric retrovi-
ral mutants contained additional protein sequences
fused to the C-terminal gag, our HIV mutants had the
extra coding sequences inserted into the N-terminal MA
domain, a domain known to play a crucial role in Gag
plasma membrane targeting. In contrast to small MA
mutations that disrupt virus particle assembly and re-
lease, large insertion mutations introduced into the MA
( 0% PAG
w
295ASSEMBLY OF HIV-1 MATRIX MUTANTSappeared not to be detrimental to extracellular particle
production. This discrepancy may be explained in differ-
ent ways. One possibility is that the large protein se-
quences inserted into our MA mutants were placed in
the central portion of the MA, downstream of the N-
terminal myristic acid moiety and N-proximal basic MA
residues, which are the most important areas involved in
Gag transport and plasma membrane targeting. Alterna-
tively and/or additionally, the duplicated 107 residues
inserted in the MA mutants were derived from the MA
domain. This may allow the MA2 and MA3 mutants to
adopt a conformation that would not significantly affect
Gag particle assembly and budding.
Although the MA2 and MA3 mutants were capable of
particle assembly and release, the virus budding of MA4
was severely defective. Reduction of the Gag size by
removing sequences dispensable for virus budding did
not appear to improve particle release, suggesting that
inhibition of virus budding may have been the result of
the MA4 mutation but not solely to size limitation. Sub-
cellular fractionation analysis indicated that the MA tan-
dem repeat mutants exhibited an increased membrane
affinity profile that correlated with the extent of added MA
copy numbers (Fig. 5A). It appears that the inserted MA
FIG. 5. Subcellular fractionation of HIV Gag proteins. 293T cells tr
subcellular fractionation as described under Materials and Methods. Po
low-salt (0.15 M NaCl), and (B) high-salt (1 M NaCl) buffers, respectively
P), corresponding to 5% of the total samples, were separated by SDS–1
eight markers (Std.) are indicated on the right in kDa.tandem repeat sequences, which contain additional for-
eign basic residues inserted at the junctions of duplica-tion mutations, contributed significantly to the increased
membrane affinity. This enhanced membrane affinity,
however, was unstable in high-ionic-strength buffers
(Fig. 5B). We do not know whether the increased mem-
brane affinity observed with the MA mutants had any
direct effect on the process of particle assembly and
budding. The MA4 mutant clearly demonstrated that the
increased membrane affinity has no positive effects on
particle production.
The sucrose density gradient fractionation analysis
revealed that MA mutants, even with a size increase of
about 60% of that of the wild-type in the case of MA4,
could still assemble and release viruslike particles with
wild-type retrovirus particle densities, suggesting that
there is no effect of Gag molecular size on particle
density. Previous reports demonstrated that retroviral
gag mutants with deletions downstream of the CA C-
terminus produced virus particles that were less dense
than those of the wild-type (Bennett et al., 1993; Jowett et
al., 1992; Wang et al., 1998). Our mutants MA2T366 and
MA3T366, with truncations of the p2 and sequences
downstream of the p2 domain, also had particle densi-
ties of 1.14–1.16 g/ml, which are lower than that of wild-
type HIV particles, although the two had a molecular size
ed with the designated constructs were harvested and subjected to
ear supernatants were divided into two equal portions, treated with (A)
actionated at 201,000 g for 15 min at 4°C. Supernatants (S) and pellets
E, and probed for Gag proteins with an anti-p24gag antibody. Molecularansfect
stnucl
, and frcomparable to or larger than the wild-type Gag. This
suggests that the mutants had an altered morphology,
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296 WANG, CHEN, AND CHIANGpossibly resulting from the effects of the C-terminal trun-
cation mutations on Gag packing. In support of this
hypothesis, the HIV C-terminal Gag sequences have
been proposed to promote Gag multimerization (Accola
et al., 1998; Morikawa et al., 2000). Moreover, recent
studies by another research group suggest that the HIV
p2 domain is a critical determinant of mature particle
formation (Gross et al., 2000; Wiegers et al., 1998). Over-
ll, our data strongly suggest that the p2 and adjacent
C domain, though not essential for viruslike particle
ssembly, are required for proper Gag packing and ac-
uisition of wild-type retrovirus particle densities, regard-
ess of the molecular size of the Gag proteins.
MATERIALS AND METHODS
lasmid construction
The HIV-1 proviral plasmid DNA in this study was
XB2C (Ratner et al., 1985). The MA duplication mutant
as constructed by recombination of two HIV gag mu-
ants HIVgptClaI and HIVgptPvuII, which contained a
alI-linker insertion at ClaI-831 and PvuII-1147, respec-
ively (Wang and Barklis, 1993). The fragment SalI-1147 to
peI-1508 of the plasmid HIVgptPvuII was replaced with
he fragment SalI-831 to SpeI-1508 of the plasmid HIVg-
tClaI, yielding the construct MA2, which contained a
andem repeat of 107-MA codons within the MA domain
Fig. 1A). Replacement of the fragment SalI-1147 to SpeI-
508 with the partial-digestion fragment ClaI-831 to SpeI-
508 of the MA2 yielded the construct MA3. By using the
ame approach, substitution of the MA3 partial-digestion
ragment ClaI-831 to SpeI-1508 for the nucleotide se-
uences SalI-1147 to SpeI-1508 generated the construct
A4. Within the constructs MA3 and MA4, the central
07-MA codons were either triplicated or quadruplicated.
To introduce the C-terminal truncation mutations into
he above MA mutants, the MA2, MA3, and MA4 were
ecombined with C-terminally truncated HIV gag mutants
449, T431, and T366. As described previously (Wang et
l., 1998), the T449, T431, and T366 had translational stop
odons replacing gag codons 449, 431, and 366, respec-
ively. Introduction of the truncation mutations into the
A2, MA3, and MA4 yielded a series of C-terminally
runcated mutants, designated MA2T449, MA2T431,
A2T366, MA3T449, MA3T431, MA3T366, MA4T449,
A4T431, and MA4T366 (Fig. 2A). Each mutant construct
as confirmed either by restriction enzyme digestion or
y DNA sequencing. All gag mutations were subcloned
nto the HIV replication-defective vector HIVgpt (Page et
l., 1990).
ell culture and transfection
293T cells were maintained in Dulbecco’s modified
agle’s medium (DMEM) supplemented with 10% fetal
alf serum. Confluent 293T cells were split 1:10 onto
o
b0-cm dishes 24 h before transfection. Twenty micro-
rams of plasmid DNA of wild-type or mutant HIVgpt
ere transfected into 293T cells by the calcium precipi-
ation method, with the addition of 50 mm chloroquine to
nhance transfection efficiency. Two to 3 days after
ransfection, culture media and cells were harvested for
rotein analysis.
rotein analysis
At 48–72 h posttransfection, culture supernatants of
ransfected 293T cells were collected and filtered
hrough 0.45-mm-pore-size filters, followed by centrifuga-
ion through 2 ml of 20% sucrose in TSE (10 mM Tris–HCl,
00 mM NaCl, 1 mM EDTA plus 0.1 mM phenylmethyl-
ulfonyl fluoride [PMSF]) at 4°C for 40 min at 274,000 g
SW41 rotor at 40,000 rpm). Viral pellets then were sus-
ended in IPB (20 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1
M EDTA, 0.1% SDS, 0.5% sodium deoxycholate, 1%
riton X-100, 0.02% sodium azide) plus 0.1 mM PMSF.
ells were rinsed with ice-cold PBS, collected in IPB plus
.1 mM PMSF, and then subjected to microcentrifugation
t 4°C for 15 min at 13,700 g (14,000 rpm) to remove cell
ebris. Supernatant and cell samples were mixed with
qual volumes of 23 sample buffer (12.5 mM Tris–HCl,
H 6.8, 2% SDS, 20% glycerol, 0.25% bromphenol blue)
nd b-mercaptoethanol to 5%, and boiled for 5 min.
amples were resolved by electrophoresis on SDS–poly-
crylamide gels and electroblotted onto nitrocellulose
embranes. Membrane-bound HIV Gag proteins were
mmunodetected by an enhanced chemiluminescence
ECL) detection system or by a colorimetric method,
sing an anti-p24gag (a mouse hybridoma clone 183-H12-
5C) or anti-p17gag (No. HB-8975; American Type Culture
ollection, Rockville, MD) monoclonal antibody as a pri-
ary antibody used at a 1:5000 dilution from purified
scites. For colorimetric immunodetection, the second-
ry antibody was a sheep anti-mouse IgG-alkaline phos-
hatase conjugate at a 1:5000 dilution (Vector Laborato-
ies, Burlingame, CA). For ECL immunodetection, the
econdary antibody was a sheep anti-mouse horserad-
sh peroxidase (HRP)-conjugated antibody at a 1:5000
ilution and procedures for HRP activity detection fol-
owed the manufacturer’s protocol (Amersham, Arlington
eights, IL). Immunodetected bands on the films or on
he blots were quantitated with a Personal Densitometer
Molecular Dynamics, Sunnyvale, CA).
ucrose density gradient fractionation
Culture supernatants of transfected 293T cells were
ollected, filtered, and centrifuged through a 2-ml 20%
ucrose cushion as described above. Viral pellets were
uspended in TSE buffer and overlaid on top of a pre-
ade 20–60% sucrose gradient consisting of 1-ml layersf 20, 30, 40, 50, and 60% sucrose in TSE, which had
een allowed to mix by sitting for 2 h. Gradients were
b
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297ASSEMBLY OF HIV-1 MATRIX MUTANTScentrifuged in an SW50.1 rotor at 40,000 rpm (274,000 g)
for 16–18 h at 4°C, and 500-ml fractions were collected
from top to bottom. The density of each fraction was
measured. Gag proteins in each fraction were precipi-
tated with 10% trichloroacetic acid (TCA), dried, and sub-
jected to SDS–PAGE analysis.
Subcellular fractionation
At 48 h posttransfection, 293T cells were rinsed twice,
pelleted in PBS, and resuspended in 500 ml hypotonic
uffer containing 10 mM Tris–HCl, pH 7.4, 1 mM EDTA
TE), and Complete protease inhibitor cocktail (Boehr-
nger Mannheim, Indianapolis, IN). The cells were then
ysed with a Wheaton dounce type A pestle after a 15-min
ncubation on ice. Cell lysates were spun at 1000 g for 10
in at 4°C. Postnuclear supernatants (PNS) were di-
ided into two portions, adjusted to 0.15 and 1 M NaCl,
espectively, and set on ice for 10 min. Samples were
hen spun at 201,000 g for 15 min at 4°C. Second super-
atants (S2) and pellets (P2) were resuspended in an
lectrophoresis sample buffer and analyzed by Western
mmunoblotting as described above.
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